# Fidelity's Biotech Investments: 72 Startups in Its Portfolio (2026) > The 72 Biotech startups Fidelity has backed, by stage: $15B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/fidelity-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series B 30 - [*B* BioNTech](https://millionrounds.com/company/biontech) - [Intellia Therapeutics](https://millionrounds.com/company/intellia-therapeutics) - [*CT* Cidara Therapeutics](https://millionrounds.com/company/cidara-therapeutics) - [Laronde](https://millionrounds.com/company/laronde) - [Wave Life Sciences](https://millionrounds.com/company/wave-life-sciences) - [Editas Medicine](https://millionrounds.com/company/editas-medicine) - [Fulcrum Therapeutics](https://millionrounds.com/company/fulcrum-therapeutics) - [Quell Therapeutics](https://millionrounds.com/company/quell-therapeutics) - [Cardurion Pharmaceuticals](https://millionrounds.com/company/cardurion-pharmaceuticals) - [Mirador Therapeutics](https://millionrounds.com/company/mirador-therapeutics) - [*CT* City Therapeutics](https://millionrounds.com/company/city-therapeutics) - [Voyager Therapeutics](https://millionrounds.com/company/voyager-therapeutics) - [Hua Medicine](https://millionrounds.com/company/hua-medicine) - [Generation Bio](https://millionrounds.com/company/generation-bio) - [Neon Therapeutics](https://millionrounds.com/company/neon-therapeutics) - [Tenaya Therapeutics](https://millionrounds.com/company/tenaya-therapeutics) - [Graphite Bio](https://millionrounds.com/company/graphite-bio) - [Prelude Therapeutics](https://millionrounds.com/company/prelude-therapeutics) - [Nohla Therapeutics](https://millionrounds.com/company/nohla-therapeutics) - [AlloVir](https://millionrounds.com/company/allovir) - [Unity Biotechnology](https://millionrounds.com/company/unity-biotechnology) - [SalioGen Therapeutics](https://millionrounds.com/company/saliogen-therapeutics) - [Akouos](https://millionrounds.com/company/akouos) - [resTORbio](https://millionrounds.com/company/restorbio) +6 more ## Series C and later 19 - [23andMe](https://millionrounds.com/company/23andme) - [Moderna](https://millionrounds.com/company/moderna) - [ElevateBio](https://millionrounds.com/company/elevatebio) - [AdvanCell](https://millionrounds.com/company/advancell) - [Outset Medical](https://millionrounds.com/company/outset-medical) - [Kry](https://millionrounds.com/company/kry) - [LifeMine Therapeutics](https://millionrounds.com/company/lifemine-therapeutics) - [Antengene](https://millionrounds.com/company/antengene) - [Triveni Bio](https://millionrounds.com/company/triveni-bio) - [Benchling](https://millionrounds.com/company/benchling) - [Allotera Therapeutics](https://millionrounds.com/company/allotera-therapeutics) - [Boundless Bio](https://millionrounds.com/company/boundless-bio) - [Endeavor BioMedicines](https://millionrounds.com/company/endeavor-biomedicines) - [Epicrispr Biotechnologies](https://millionrounds.com/company/epicrispr-biotechnologies) - [Bright Peak Therapeutics](https://millionrounds.com/company/bright-peak-therapeutics) - [Shockwave Medical](https://millionrounds.com/company/shockwave-medical) - [*C* Codiak](https://millionrounds.com/company/codiak) - [Cibus](https://millionrounds.com/company/cibus) - [*O* ORIC](https://millionrounds.com/company/oric) ## Stage not reported 18 - [Nuvalent](https://millionrounds.com/company/nuvalent) - [Century Therapeutics](https://millionrounds.com/company/century-therapeutics) - [Monte Rosa Therapeutics](https://millionrounds.com/company/monte-rosa-therapeutics) - [Vera Therapeutics](https://millionrounds.com/company/vera-therapeutics) - [Rapport Therapeutics](https://millionrounds.com/company/rapport-therapeutics) - [Roivant Sciences](https://millionrounds.com/company/roivant-sciences) - [10X Genomics](https://millionrounds.com/company/10x-genomics) - [*I* Inscripta](https://millionrounds.com/company/inscripta) - [Kaleido BioSciences](https://millionrounds.com/company/kaleido-biosciences) - [Skyhawk Therapeutics](https://millionrounds.com/company/skyhawk-therapeutics) - [Invivyd](https://millionrounds.com/company/invivyd) - [*CC* Castle Creek Pharma](https://millionrounds.com/company/castle-creek-pharma) - [Castle Creek Pharmaceuticals](https://millionrounds.com/company/castle-creek-pharmaceuticals) - [Ikena Oncology](https://millionrounds.com/company/ikena-oncology) - [Omega Therapeutics](https://millionrounds.com/company/omega-therapeutics) - [*SB* Sienna Biopharmaceuticals](https://millionrounds.com/company/sienna-biopharmaceuticals) - [Axcella](https://millionrounds.com/company/axcella) - [Sonoma Biotherapeutics](https://millionrounds.com/company/sonoma-biotherapeutics) ## Series A 5 - [Nuvation Bio](https://millionrounds.com/company/nuvation-bio) - [Treeline Biosciences](https://millionrounds.com/company/treeline-biosciences) - [*GT* Gemini Therapeutics](https://millionrounds.com/company/gemini-therapeutics) - [Codiak Biosciences](https://millionrounds.com/company/codiak-biosciences) - [Shoulder Innovations](https://millionrounds.com/company/shoulder-innovations) ## Segment by segment ### Series B 30 startups · $6.4B raised - [*B* **BioNTech**](https://millionrounds.com/company/biontech) Germany $687M - [**Intellia Therapeutics**](https://millionrounds.com/company/intellia-therapeutics) Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments. United States $485M - [*CT* **Cidara Therapeutics**](https://millionrounds.com/company/cidara-therapeutics) Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics. United States $463M - [**Laronde**](https://millionrounds.com/company/laronde) Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body. United States $440M - [**Wave Life Sciences**](https://millionrounds.com/company/wave-life-sciences) Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling United States $434M - [**Editas Medicine**](https://millionrounds.com/company/editas-medicine) Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases. United States $335M - [**Fulcrum Therapeutics**](https://millionrounds.com/company/fulcrum-therapeutics) Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause. United States $310M - [**Quell Therapeutics**](https://millionrounds.com/company/quell-therapeutics) Quell Therapeutics is a cell therapy company United Kingdom $274M ### Series C and later 19 startups · $4.7B raised - [**23andMe**](https://millionrounds.com/company/23andme) United States $729M - [**Moderna**](https://millionrounds.com/company/moderna) Learn how we’re changing the world of medicine. United States $675M - [**ElevateBio**](https://millionrounds.com/company/elevatebio) ElevateBio is a biotechnology company based in Waltham, Massachusetts, founded in 2017. United States $551M - [**AdvanCell**](https://millionrounds.com/company/advancell) AdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment. Australia $438M - [**Outset Medical**](https://millionrounds.com/company/outset-medical) Outset Medical is a medical technology company that offers reimagining dialysis for patients and providers. United States $360M - [**Kry**](https://millionrounds.com/company/kry) Kry is a leading digital healthcare provider based in Sweden, founded in 2015 by Johannes Schildt. Sweden $249M - [**LifeMine Therapeutics**](https://millionrounds.com/company/lifemine-therapeutics) LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines. United States $230M - [**Antengene**](https://millionrounds.com/company/antengene) Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor. China $217M ### Stage not reported 18 startups · $3.0B raised - [**Nuvalent**](https://millionrounds.com/company/nuvalent) Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines. United States $500M - [**Century Therapeutics**](https://millionrounds.com/company/century-therapeutics) Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies. United States $385M - [**Monte Rosa Therapeutics**](https://millionrounds.com/company/monte-rosa-therapeutics) Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways. Switzerland $300M - [**Vera Therapeutics**](https://millionrounds.com/company/vera-therapeutics) Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential. United States $261M - [**Rapport Therapeutics**](https://millionrounds.com/company/rapport-therapeutics) Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders. United States $250M - [**Roivant Sciences**](https://millionrounds.com/company/roivant-sciences) Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. United States $230M - [**10X Genomics**](https://millionrounds.com/company/10x-genomics) 10X Genomics ELV solutions and security systems company that provides an innovative genomics platform. United States $215M - [*I* **Inscripta**](https://millionrounds.com/company/inscripta) United States $205M ### Series A 5 startups · $1.2B raised - [**Nuvation Bio**](https://millionrounds.com/company/nuvation-bio) Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology. United States $675M - [**Treeline Biosciences**](https://millionrounds.com/company/treeline-biosciences) Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions. United States $200M - [*GT* **Gemini Therapeutics**](https://millionrounds.com/company/gemini-therapeutics) Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases. United States $138M - [**Codiak Biosciences**](https://millionrounds.com/company/codiak-biosciences) Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics. United States $100M - [**Shoulder Innovations**](https://millionrounds.com/company/shoulder-innovations) Shoulder Innovations is a medical device company that develops inset glenoid fixation technology. United States $49M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Fidelity as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Fidelity's AI portfolio** 44 startups · $522B](https://millionrounds.com/portfolio-maps/fidelity-ai-portfolio)[Sector portfolio **Fidelity's Fintech portfolio** 20 startups · $10B](https://millionrounds.com/portfolio-maps/fidelity-fintech-portfolio)[Sector portfolio **Fidelity's Healthtech portfolio** 10 startups · $7.0B](https://millionrounds.com/portfolio-maps/fidelity-healthtech-portfolio)[Co-investors **Who invests with Fidelity** 349 co-investors](https://millionrounds.com/portfolio-maps/fidelity-co-investors)[Portfolio map **Fidelity portfolio map** 196 startups · $618B](https://millionrounds.com/portfolio-maps/fidelity-portfolio-map)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio) ## Raising from investors like Fidelity? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)